Although there are substantial data and plausibility arguments suppo- ing many conditions as contributory components of pathways to illness and disease end points, we have, historically, lacked an e?ective method- ogy for identifying the structure of the full pathways.
Read More
Although there are substantial data and plausibility arguments suppo- ing many conditions as contributory components of pathways to illness and disease end points, we have, historically, lacked an e?ective method- ogy for identifying the structure of the full pathways.
Read Less